- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 205/09 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
Patent holdings for IPC class C07D 205/09
Total number of patents in this class: 5
10-year publication summary
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2204 |
1 |
| American University | 56 |
1 |
| Orchid Chemicals & Pharmaceuticals Limited | 39 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2976 |
1 |
| Inflazome Limited | 84 |
1 |
| Other owners | 0 |